Pfizer, Takeda Units End Antitrust Case Over Protonix Patent

Law360, New York (July 17, 2013, 6:01 PM EDT) -- A New Jersey federal court on Monday signed off on an agreement dismissing putative class antitrust allegations that Pfizer Inc.'s Wyeth and Takeda Pharmaceutical Co. Ltd.'s Altana Pharma AG fraudulently obtained a patent related to the acid reflux drug Protonix.

U.S. District Judge Jose L. Linares approved a stipulation of dismissal in a proposed antitrust class action brought against Wyeth and Altana. The suit alleged that Altana secured a patent on Protonix through fraud and, in turn, used that invalid patent to file sham infringement allegations...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.